Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions.
Gil-Guillen VF, Balsa A, Bernárdez B, Valdés Y Llorca C, Márquez-Contreras E, de la Haba-Rodríguez J, Castellano JM, Gómez-Martínez J. Gil-Guillen VF, et al. Among authors: gomez martinez j. Int J Environ Res Public Health. 2022 Sep 23;19(19):12036. doi: 10.3390/ijerph191912036. Int J Environ Res Public Health. 2022. PMID: 36231341 Free PMC article. Review.
A cost utility analysis alongside a cluster-randomised trial evaluating a minor ailment service compared to usual care in community pharmacy.
Amador-Fernández N, Benrimoj SI, García-Mochón L, García-Cárdenas V, Dineen-Griffin S, Gastelurrutia MÁ, Gómez-Martínez JC, Colomer-Molina V, Martínez-Martínez F. Amador-Fernández N, et al. BMC Health Serv Res. 2021 Nov 20;21(1):1253. doi: 10.1186/s12913-021-07188-4. BMC Health Serv Res. 2021. PMID: 34798895 Free PMC article. Clinical Trial.
Smoking cessation intervention in the community pharmacy: Cost-effectiveness of a non-randomized cluster-controlled trial at 12-months' follow-up.
Gómez Martínez JC, Gaztelurrutia Lavesa L, Mendoza Barbero A, Plaza Zamora J, Lage Piñón M, Aguiló Juanola M, Climent Catalá M, de Andrés Dirube A, García Moreno L, Jaraiz Magariños I, Moral Ajado M, Sánchez Marcos N. Gómez Martínez JC, et al. Res Social Adm Pharm. 2024 Jan;20(1):19-27. doi: 10.1016/j.sapharm.2023.09.003. Epub 2023 Sep 7. Res Social Adm Pharm. 2024. PMID: 37704533 Free article. Clinical Trial.
Comparison of the MIPS technique versus linear incision with tissue preservation in osseointegrated implants in the Ponto model®.
Fernández-Cedrón Bermejo C, Sánchez Fernández E, Costales Marcos M, Núñez Batalla FJ, Luis Llorente Pendás J, Gómez Martínez JR. Fernández-Cedrón Bermejo C, et al. Among authors: gomez martinez jr. Acta Otorrinolaringol Esp (Engl Ed). 2024 Mar 1:S2173-5735(24)00038-3. doi: 10.1016/j.otoeng.2023.10.010. Online ahead of print. Acta Otorrinolaringol Esp (Engl Ed). 2024. PMID: 38432617
Clinical practice guideline on the management of vestibular schwannoma.
Lassaletta L, Acle Cervera L, Altuna X, Amilibia Cabeza E, Arístegui Ruiz M, Batuecas Caletrio Á, Benítez Del Rosario J, Cabanillas Farpón R, Costales Marcos M, Escada P, Espinosa-Sánchez JM, García Leal R, Gavilán J, Gómez Martínez J, González-Aguado R, Martinez-Glez V, Guerra Jiménez G, Harguindey Antolí-Candela A, Hernández García BJ, Orús Dotú C, Polo López R, Manrique M, Martín Sanz E, Martínez Álvarez R, Martínez H, Martínez-Martínez M, Rey-Martinez J, Ropero Romero F, Santa Cruz Ruiz S, Vallejo LÁ, Soto Varela A, Varela-Nieto I, Morales Puebla JM. Lassaletta L, et al. Among authors: gomez martinez j. Acta Otorrinolaringol Esp (Engl Ed). 2024 Mar-Apr;75(2):108-128. doi: 10.1016/j.otoeng.2023.10.005. Epub 2024 Feb 10. Acta Otorrinolaringol Esp (Engl Ed). 2024. PMID: 38346489
Enlarged vestibular aqueduct as a cause of postneonatal deafness.
Fernández-Cedrón C, Sánchez-Fernández P, Guntín-García M, Sandoval-Menéndez I, Gómez-Martínez J, Llorente-Pendás JL, Núñez-Batalla F. Fernández-Cedrón C, et al. Among authors: gomez martinez j. Acta Otorrinolaringol Esp (Engl Ed). 2024 Feb 9:S2173-5735(24)00018-8. doi: 10.1016/j.otoeng.2023.10.004. Online ahead of print. Acta Otorrinolaringol Esp (Engl Ed). 2024. PMID: 38342426
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
Universal neonatal hearing screening and delayed hearing loss or late-developmental hearing loss.
Núñez Batalla FJ, Fernández-Cedrón Bermejo C, Guntín García M, Sandoval Menéndez I, Fresno Díaz E, Gómez Martínez JR, Llorente Pendás JL. Núñez Batalla FJ, et al. Among authors: gomez martinez jr. Acta Otorrinolaringol Esp (Engl Ed). 2023 Sep-Oct;74(5):283-289. doi: 10.1016/j.otoeng.2022.10.007. Epub 2023 May 4. Acta Otorrinolaringol Esp (Engl Ed). 2023. PMID: 37149133
57 results